Every year on February 4 , the world unites to observe World Cancer Day—a powerful reminder that cancer is not just a medical condition, but a deeply human experience. It affects individuals, families, communities, and entire healthcare systems. For many of us working in genetics and healthcare, this day carries special meaning. It represents both the urgency of the cancer burden and the extraordinary promise of science. World Cancer Day is about awareness—but it is also abou

Genetic testing today touches nearly every part of healthcare. We use it to diagnose rare diseases, guide cancer treatment, assess pregnancy-related risks, and even select the right medications through pharmacogenomics. As its influence grows, so does our responsibility to ensure that the entire process—from referral to result communication—is conducted safely and ethically. A recent study published in the European Journal of Human Genetics  takes an important step in this di

Why the Technology Behind Cancer Gene Panels Matters Genetic screening for inherited cancer risk has become a cornerstone of modern precision medicine. By analyzing specific genes known to influence cancer susceptibility — such as BRCA1 , BRCA2 , TP53 , PTEN , and the mismatch repair genes MLH1  and MSH2  — clinicians can identify individuals at high risk and guide preventive or targeted treatment strategies. The American College of Medical Genetics and Genomics (ACMG)  provi